Franc Gregori is a clinical pharmacist who worked with Boots, Eli Lilly, and Pfizer before moving into the City as an analyst. He has worked as a life sciences and healthcare analyst at various institutions, including Robert Fleming, BZW and BNP Paribas, covering everything from large pharma down to micro-cap healthcare service companies. He has been involved in a number of major transactions and has considerable experience of M&A, IPOs, and other advisory and corporate activities.

He gained his pharmaceutical qualifications at the Welsh School of Pharmacy and King’s College, London and has an MBA from Cranfield business school.